Moderna Inc

Common Name
Moderna
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
5,800
Ticker
MRNA
Exchange
NASDAQ/NGS
Description
Moderna Inc. is a biotechnology company focused on developing transformative medicines based on messenger RNA (mRNA) technology. Its primary function is to research and produce a broad spectrum of vac...

Moderna's GHG Emissions Data Preview

In 2023, Moderna completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).

However, Moderna has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Market-Based
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Location-Based
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into Moderna's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Moderna amounted to 22,746 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Moderna increased by 2.03%, suggesting that the company faced challenges in reducing its emissions from its core operations.

Moderna's Scope 1 Emissions Over Time

20212022202303 k6 k9 k12 ktCO2e+26%-3%
  • Total Scope 1
  • Year-over-Year Change

What are Moderna's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Moderna were 11,240 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).

Has Moderna reduced its Scope 1 emissions over time?

Since 2021, Moderna's Scope 1 emissions have increased by 22.95%, reflecting a rising long-term trend in Scope 1 emissions over time.

Compared to the previous year (2022), Moderna's Scope 1 emissions decreased by 2.79%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.

What are Moderna's Scope 2 emissions?

In 2023, Moderna reported Scope 2 greenhouse gas (GHG) emissions of 431 tCOâ‚‚e using the market-based method, and 11,506 tCOâ‚‚e using the location-based method.

Has Moderna reduced its Scope 2 emissions over time?

Since 2021, Moderna's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have increased by 41.72%, reflecting a rising long-term trend in Scope 2 emissions over time.

Compared to the previous year (2022), Moderna's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Moderna 's emissions have plateaued with no significant change in its energy consumption footprint.

What methodology does Moderna use for Scope 2 reporting?

In 2023, Moderna reported its Scope 2 emissions using the market-based method and using the location-based method.

Moderna's Scope 2 Emissions Over Time

20212022202303 k6 k9 k12 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based
Want Full Access to Moderna's GHG Emissions Dataset?
Sign Up